Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $86,578 - $101,201
2,698 Added 20.38%
15,938 $528,000
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $127,142 - $147,100
3,520 Added 36.21%
13,240 $485,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $639,457 - $832,479
-16,234 Reduced 62.55%
9,720 $396,000
Q4 2022

Jan 12, 2023

BUY
$41.75 - $54.5 $541,080 - $706,320
12,960 Added 99.74%
25,954 $0
Q3 2022

Oct 20, 2022

BUY
$43.76 - $53.42 $80,868 - $98,720
1,848 Added 16.58%
12,994 $569,000
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $32,105 - $38,067
-690 Reduced 5.83%
11,146 $584,000
Q1 2022

May 06, 2022

BUY
$45.75 - $56.69 $63,821 - $79,082
1,395 Added 13.36%
11,836 $613,000
Q4 2021

Jan 28, 2022

BUY
$41.32 - $61.25 $37,394 - $55,431
905 Added 9.49%
10,441 $617,000
Q3 2021

Nov 03, 2021

BUY
$39.25 - $50.42 $20,292 - $26,067
517 Added 5.73%
9,536 $410,000
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $57,994 - $65,698
1,615 Added 21.81%
9,019 $353,000
Q1 2021

Aug 16, 2021

BUY
$33.49 - $37.77 $247,959 - $279,649
7,404 New
7,404 $268,000
Q2 2020

Jul 15, 2020

SELL
$30.12 - $36.54 $9,879 - $11,985
-328 Closed
0 $0
Q1 2020

Apr 23, 2020

BUY
$27.03 - $38.62 $8,865 - $12,667
328 New
328 $11,000
Q1 2019

Apr 30, 2019

SELL
$37.5 - $41.2 $970,125 - $1.07 Million
-25,870 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $71,015 - $80,965
1,846 Added 7.68%
25,870 $1.13 Million
Q3 2018

Oct 31, 2018

BUY
$34.47 - $41.81 $462,621 - $561,132
13,421 Added 126.58%
24,024 $1.06 Million
Q2 2018

Aug 08, 2018

BUY
$32.98 - $35.16 $344,542 - $367,316
10,447 Added 6696.79%
10,603 $385,000
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $4,836 - $5,327
156
156 $6,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Accuvest Global Advisors Portfolio

Follow Accuvest Global Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accuvest Global Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Accuvest Global Advisors with notifications on news.